Ikena Oncology(IKNA) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

IKNA Ikena Oncology

Watchlist

1.360
-0.030-2.16%

Close Mar 13 16:00 ET

1.340
-0.020-1.47%

Post 16:11 ET

65.63MMarket Cap-1.33P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Analysts' Top Healthcare Picks: Ikena Oncology (IKNA), PMV Pharmaceuticals (PMVP)
TipRanksMar 7 15:20 ET
Ikena Oncology: Investor Caution as Dividend Payments Remain Unlikely
TipRanksMar 7 01:02 ET
Ikena Oncology | 10-K: FY2024 Annual Report
SECMar 6 08:11 ET · Announcements
Foundery Immune Studio, LLC Acquires Rights to a Suite of Next-Generation Clinical Stage Immunotherapies
PR NewswireJan 8 08:01 ET
Ikena Oncology (IKNA) Moves to Buy: Rationale Behind the Upgrade
Yahoo FinanceDec 30, 2024 12:00 ET
William Blair Maintains Ikena Oncology(IKNA.US) With Buy Rating
Moomoo NewsDec 29, 2024 07:31 ET · Ratings

Comments

Jaguar8

Dec 24, 2024 08:51

🔴Christmas Watchlist December 24,2024 😉. NFA. This is my last watchlist for the year

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits. GREED will make losr and get trapped.
5. Always remember shorts include dark pools.
6. Most importantly, DON’T BLAME ME for your losses. I already give watchlist and stock education. The ball is on you. I give you “watchlist” which means its on w...

Rumble shares continue to surge: Time to follow crypto money?

Trytosaveabit

Dec 23, 2024 22:15

Grrrrr!

$Ikena Oncology (IKNA.US)$ They removed my bid from the lit board! Grrrr! Im going to cancel and re bid! Grrrrr

Trytosaveabit

Dec 23, 2024 21:47

Update

$Ikena Oncology (IKNA.US)$ Resume Quotes at 8:55AM! Resume Trading at 9:00AM

Trytosaveabit

Dec 23, 2024 21:40

News

$Ikena Oncology (IKNA.US)$ Ikena And Inmagene Enter Merger Agreement; $175M To Support IMG-007 Development, Includes $75M Private Placement; Combined Company ImageneBio To Target Atopic Dermatitis; Expected Close Mid-2025 And Trade On Nasdaq Under The Ticker "IMA"
Benzinga· 3 mins ago
Inmagene Biopharmaceuticals is a clinical stage company focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody with an extended half-life and a silenced ADCC function
The transaction is exp...

Jaguar8

Dec 23, 2024 21:34

NEWS

$Ikena Oncology (IKNA.US)$
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement
Ikena Oncology (NASDAQ: IKNA) and Inmagene Biopharmaceuticals have announced a definitive merger agreement, along with a $75 million private placement. The transaction, expected to close in mid-2025, will result in approximately $175 million to support the development of IMG-007, a non-depleting anti-OX40 monoclonal antibody.
The private placement includes investments ...

IKNA Ikena Oncology

Trade Overview

Capital Trend

News

Comments

Trending Stocks